Project title: DEVELOPMENT OF DISEASE-SPECIFIC TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS

Company name : VERTO MEDICAL LTD.


TECHNOLOGICAL FIELD
Biopharmaceutical

KEY WORDS
Lupus, Systemic Lupus
Erythematosus


PROJECT SUMMARY
VERTO MEDICAL LTD. is a biopharmaceutical company focused on the
research and development of highly specific therapeutic products
for the treatment of Lupus, a life threatening antibody-mediated
disease. Lupus, or Systemic Lupus Erythematosus by its full name
(SLE), is caused by an abnormal production of antibodies that
attack healthy tissues. Current treatments for Lupus address only
the symptoms of the disease, or non-specifically suppress the
normal operation of the immune system, often leading to severe,
negative side effects and hospitalization.


ENTREPRENEUR
Prof. Yaakov Naparstek


PROJECT STATUS
The company has graduated from the incubator and operates
independently.


COOPERATION REQUIRED
Financial investments, Strategic partnership.
---------------------------------------------------------------
TEL: 972-54-4259138; FAX: 972-3-6965460; E-MAIL:
info@vertomedical.com


Request for more information, about this project.

Note - you have to be registered in this server to request information. If you haven't done so yet, please:
Register in this server and your requests will be forwarded to the developer, who will contact you directly

List of projects that you already requested more information about


Incubator contact:
Mr. Haim Eliash
NEW INDUSTRIAL PARK, BUILDING 7
POB 620, YOKNEAM 20692, ISRAEL
972-4-9090000
972-4-9090001
home@naiot.com